A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Normothermic Ex Vivo Liver Machine Perfusion in Mouse

5K views

⸱

DOI:

10.3791/65363

⸱

September 25th, 2023

 ,  ,  ,  , 
1Experimental Transplantation Surgery, Department of General, Visceral and Vascular Surgery, Jena University Hospital, 2Institute of Pathology, Klinikum Chemnitz GmbH, 3Department of Pathology, Faculty of Veterinary Medicine, Menoufia University

In This Article

Summary

A normothermic ex vivo liver perfusion (NEVLP) system was created for mouse livers. This system requires experience in microsurgery but allows for reproducible perfusion results. The ability to utilize mouse livers facilitates the investigation of molecular pathways to identify novel perfusate additives and enables the execution of experiments focused on organ repair.

Abstract

This protocol presents an optimized erythrocytes-free NEVLP system using mouse livers. Ex vivo preservation of mouse livers was achieved by employing modified cannulas and techniques adapted from conventional commercial ex vivo perfusion equipment. The system was utilized to evaluate the preservation outcomes following 12 h of perfusion. C57BL/6J mice served as liver donors, and the livers were explanted by cannulating the portal vein (PV) and bile duct (BD), and subsequently flushing the organ with warm (37 °C) heparinized saline. Then, the explanted livers were transferred to the perfusion chamber and subjected to normothermic oxygenated machine perfusion (NEVLP). Inlet and outlet perfusate samples were collected at 3 h intervals for perfusate analysis. Upon completion of the perfusion, liver samples were obtained for histological analysis, with morphological integrity assessed using modified Suzuki-Score through Hematoxylin-Eosin (HE) staining. The optimization experiments yielded the following findings: (1) mice weighing over 30 g were deemed more suitable for the experiment due to the larger size of their bile duct (BD). (2) a 2 Fr (outer diameter = 0.66 mm) polyurethane cannula was better suited for cannulating the portal vein (PV) when compared to a polypropylene cannula. This was attributed to the polyurethane material's enhanced grip, resulting in reduced catheter slippage during the transfer from the body to the organ chamber. (3) for cannulation of the bile duct (BD), a 1 Fr (outer diameter = 0.33 mm) polyurethane cannula was found to be more effective compared to the polypropylene UT - 03 (outer diameter = 0.30 mm) cannula. With this optimized protocol, mouse livers were successfully preserved for a duration of 12 h without significant impact on the histological structure. Hematoxylin-Eosin (HE) staining revealed a well-preserved morphological architecture of the liver, characterized by predominantly viable hepatocytes with clearly visible nuclei and mild dilation of hepatic sinusoids.

Introduction

Liver transplantation represents the gold standard treatment for individuals with end-stage liver disease. Regrettably, the demand for donor organs surpasses the available supply, leading to a significant shortage. In 2021, approximately 24,936 patients were on the waiting list for a liver graft, while only 9,234 transplants were successfully performed1. The significant disparity between the supply and demand of liver grafts highlights the pressing necessity to investigate alternative strategies to broaden the donor pool and enhance the accessibility of liver grafts. One way of expanding the donor pool is to use marginal donors2. Marginal donors include those with advanced age, moderate or severe steatosis. Although the transplantation of marginal organs may yield favorable outcomes, the overall results remain suboptimal. As a result, the development of therapeutic strategies aimed at enhancing the function of marginal donors is currently underway3,4.

One of the strategies is to use machine perfusion, especially normothermic oxygenated machine perfusion, to improve the function of these marginal organs5. However, there is still a limited understanding of the molecular mechanisms that underlie the beneficial effects of normothermic oxygenated machine perfusion (NEVLP). Mice, with their abundant availability of genetically modified strains, serve as valuable models for investigating molecular pathways. For instance, the significance of autophagy pathways in mitigating hepatic ischemia-reperfusion injury has been increasingly recognized6,7. One important molecular pathway in the hepatic ischemia-reperfusion injury is the miR-20b-5p/ATG7 pathway8. Currently, there are a number of ATG knockout and conditional knock-out mouse strains available but no corresponding rat strains9.

Based on this background, the aim was to generate a miniaturized NEVLP platform for mouse liver grafts. This platform would facilitate the exploration and evaluation of potential genetically modified strategies aimed at improving the functionality of the donor's liver. Additionally, it was essential for the system to be suitable for long-term perfusion, enabling the ex vivo treatment of the liver, commonly referred to as "organ repair."

Considering the limited availability of relevant in vitro data on mouse liver perfusion, the literature review focused on studies conducted in rats. A systematic search of literature spanning from 2010 to 2022 was performed using keywords such as "normothermic liver perfusion," "ex vivo or in vitro," and "rats". This search aimed to identify optimal conditions in rodents, allowing us to determine the most appropriate approach.

The perfusion system consists of a sealed water-jacketed glass buffer reservoir, a peristaltic roller pump, an oxygenator, a bubble trap, a heat exchanger, an organ chamber, and a closed cycling tubing system (Figure 1). The system ensures precise maintenance of a constant perfusion temperature of 37 °C using a dedicated thermo-static machine. The peristaltic roller pump drives the flow of the perfusate throughout the circuit. The perfusion circuit initiates at the insulated water-jacketed reservoir. Subsequently, the perfusate is directed through the oxygenator, which receives a gas mixture of 95% oxygen and 5% carbon dioxide from a dedicated gas bottle. Following oxygenation, the perfusate passes through the bubble trap, wherein any entrapped bubbles are redirected back to the reservoir by the peristaltic pump. The remaining perfusate flows through the heat exchanger and enters the organ chamber, from where it returns to the reservoir.

Here, we report our experiences establishing a NEVLP for mouse livers and share the promising results of a pilot experiment performed using the oxygenated medium without oxygen carriers.

Access restricted. Please log in or start a trial to view this content.

Protocol

Animal experiments were performed according to the current German regulations and guidelines for animal welfare and the ARRIVE guidelines for Reporting Animal Research. The animal experiment protocol was approved by the Thüringer Landesamt für Verbraucherschutz, Thuringia, Germany (Approval-Number: UKJ - 17 - 106).

NOTE: Male C57BL/6J mice weighing 34 ± 4 g (mean ± standard error of the mean [SEM]) were used as liver donors. They were maintained under controlled environmental conditions (50% humidity and 18 - 23 °C) with free access to standard mouse chow and water. Throughout the surgical procedure, a respiratory rate exceeding 60 breaths/min was maintained, and body temperature was kept above 34 °C.

1. Preparation

  1. Setting up the operation table
    1. Autoclave all surgical instruments and consumables for sterilization purposes.
    2. Turn on all equipment, including the warming board and electrocoagulation.
    3. Place one 50 mL syringe with 25 mL heparinized (2,500 U/L) saline in a warm incubator (37 °C).
    4. Place the surgical instruments, the 6 - 0 silk suture, sterile small cotton applicator, veterinary saline (500 mL), and non-woven gauze sponges (10 cm x 10 cm) on the operation table appropriately.
    5. Place a 26 G needle on the operation table to create a small hole in the lid of the 0.5 mL microcentrifuge tube to receive the biliary tube for bile collection.
    6. Place the cannula (1 Fr polyurethane cannula or UT - 03 polyethylene cannula) and a sterilized 0.5 mL microcentrifuge tube for bile collection on the operation table.
  2. Self-made portal vein cannula
    1. Hold the 2 Fr cannula with forceps and puncture the wall with a 30 G needle at a 1 cm distance from the end of the cannula. Push the needle through the cannula until the tip of the needle becomes visible.
    2. Trim the tip of the cannula resulting in a sharp triangle.
  3. Preparation of heparinized saline
    1. Prepare 25 mL of heparinized saline with a final concentration of 2,500 IU/mL.
    2. Remove all air bubbles and place the syringe in the 40 °C incubator.
  4. Demonstration of the perfusion system
    1. See Figure 1 for the main components of the machine perfusion system.
  5. Set up of the organ chamber
    1. See Figure 2 for the layout of the organ chamber.
  6. Set up of the perfusion system
    1. Turn on the lab chart program for pressure monitoring.
    2. Connect the pressure calibrator and pressure sensor at the organ chamber level.
    3. Adjust the pressure calibrator to read 0 mmHg and check the corresponding value on the pressure control software.
    4. Adjust the pressure calibrator to read 20 mmHg and again check the corresponding value on the pressure control software.
    5. Turn on the water bath, and prewarm the organ chamber to 40 °C.
    6. Flush the entire plumbing system twice with distilled deionized water for 30 min each, ensuring complete removal of the sanitizing solution.
    7. Initiate the circulation of the disinfection solution throughout the entire system for a duration of 20 min to ensure thorough disinfection.
    8. Turn on the gas mixture (95% oxygen (O2) and 5% carbon dioxide (CO2).
  7. Perfusate filling
    1. Supplement 250 mL of Williams' E medium with 50 mL of fetal bovine serum, 3 mL of penicillin/ streptomycin (1 mg/mL), 0.17 mL of insulin (100 IE/mL), 0.34 mL of heparin (5000 U/mL), and 0.07 mL of hydrocortisone (100 mg/2 mL) to prepare the complete Williams' E medium.
    2. Add equal volumes (150 mL) of perfusate to the reservoir and the organ chamber to prime the system.
      NOTE: Special attention must be paid to maintain sterility during the filling process. The perfusate is constantly pumped through these two key components of the closed recirculating machine perfusion.
    3. Turn on the peristaltic pump at medium speed (15 mL/min) to prime the perfusion system with the oxygenated medium.

2. Liver explantation

  1. Pre-surgery preparation
    1. Weigh the animal. Prepare the analgesic buprenorphine (0.3 mg/mL) (0.05 mg/kg body weight).
    2. Connect the induction chamber with the wall socket. Turn oxygen to 0.5 L/min. Turn isoflurane to 3%.
    3. Place the animal in the chamber until deep anesthesia (righting reflex positive) is reached.
    4. Use a micro syringe to apply body weight-adapted dose of analgesia subcutaneously.
    5. Use an electric shaver to trim the fur on the abdominal skin.
    6. Transfer the mouse to the operation table and turn on the isoflurane vaporizer to 2.5% to maintain anesthesia. Confirm the depth of anesthesia by testing the interdigital toe reflex.
  2. Preparation of the mouse abdomen
    1. Place the mouse in a supine position.
    2. Test interdigital reflex to double confirm the appropriate depth of anesthesia. Fix all four limbs with tape.
    3. Disinfect both sides of the abdomen to the mid-axillary line using three consecutive rounds of iodine-alcohol. Use non-woven sterilized gauze to cover the area around the surgical field.
    4. Make a 3 cm transverse incision 1 cm below the xiphoid in the abdominal area of the mouse using Metzenbaum baby scissors and surgical forceps.
    5. Extend the skin incision bilaterally to the midaxillary line on both sides.
    6. Carefully make a 2 cm longitudinal incision along the linea alba using spring scissors.
    7. Cut through the abdominal muscle layer with electrocoagulation and Vannas spring scissors.
    8. Carefully place a piece of wet gauze to protect the liver from electrocoagulation.
    9. Use a 6 - 0 silk suture with the round needle to retract the xiphoid process for better exposure of the coronary ligament.
    10. Use two rib retractors to fully expose the abdominal cavity of the mouse.
    11. Carefully move the small intestine out of the abdominal cavity with a wet cotton swab to fully expose the hilum.
  3. Common bile duct preparation
    1. Transect the falciform, phrenic, and gastrohepatic ligaments with sharp scissors.
    2. Carefully free the common bile duct using fine curved forceps without teeth.
      ​NOTE: The common bile duct is very easily damaged and breaks. Once it breaks, it cannot be cannulated. Due to the direction of the anatomical position, curved forceps are better to be used.
    3. Place two 6 - 0 silk suture loops over the common bile duct in preparation for the next step.
  4. Common bile duct cannulation
    1. Carefully puncture the bile duct with a 30 G needle. Use pointed curved forceps to enlarge the small hole to fit the bile duct cannulation.
    2. Use vessel cannulation forceps to grasp the bile duct cannula and push it into the bile duct.
    3. Double secure the cannula with the preset 6 - 0 suture loops.
      NOTE: During the cannulation, resistance by bile is felt. If the force is not well controlled, the cannula will be pushed out of the biliary tract by the pressure of bile outflow. Carefully adjust the depth of the cannula. If it is too deep, it may damage the bile duct, and if it is not deep enough, it may slip out.
    4. Observe the bile flow in the cannula after successful cannulation.
  5. Portal vein preparation
    1. Clamp the portal vein with flat forceps and carefully free the connective tissue with curved forceps. Do not pull hard to avoid causing tearing of the portal vein. Once the portal vein is damaged, it is difficult to re-cannulate the portal vein.
    2. Dissect the PV just superior to the bifurcation and place the first suture loop using 6 - 0 silk suture on PV close to the confluence for later use.
    3. Place the second suture loop for later fixation of the PV as close to the hepatic hilum as possible.
  6. Portal vein cannulation
    1. Use an arterial clip to close the distal portal vein.
    2. Very carefully, puncture the portal vein with one of the above portal vein cannulas. Blood flow can be clearly observed within the cannula after a successful puncture.
    3. Secure the PV cannula with the pre-placed 6 - 0 suture loop.
  7. Liver flushing
    1. Increase isoflurane to 5% and euthanize the mouse with an overdose of isoflurane inhalation.
    2. Take prewarmed heparin saline solution from the incubator. Remove all air bubbles formed inside the heparinized saline.
    3. Fix the syringe with prewarmed heparinized saline into the syringe pump.
    4. Connect the extension tube of the syringe pump to the cannula of the portal vein, adjust the speed to 2 mL/min, and start the liver flushing.
    5. Observe the color of the liver at the end of the flushing procedure. Excise the liver once the color turns to a homogenous yellow.
    6. Transect the diaphragm, suprahepatic inferior vena cava, infra hepatic vena cava, hepatic artery, distal portal vein, and any remaining connective tissue.
    7. Place the liver into the Petri dish.

3. Liver and chamber connection

  1. Liver transfer
    1. Carefully transfer the liver into the organ chamber using a Petri dish.
    2. Keep a small amount of saline in the Petri dish to prevent the liver from drying out.
      NOTE: Portal vein and bile duct can easily be twisted during this procedure, which may affect liver perfusion and bile collection.
  2. Portal vein cannula connection
    1. Slowly infuse normal saline into the portal vein cannula with a syringe to evacuate the air bubbles in the cannula.
    2. Connect the portal vein cannula into the perfusate outflow tube in the organ chamber.
  3. Bile duct cannula connection
    1. Guide the mouse bile duct cannula through the valve of a rubber cap which is connected to the organ chamber.
    2. Insert the bile duct cannula into a pre-prepared 0.5 mL microtube with a small hole in the lid.
    3. Place the microtube on clay outside of the organ chamber.

4. Adjust the flow rate according to PV pressure

  1. Turn on the peristaltic pump from 1 mL/min.
  2. Check the portal vein pressure reading to adjust the flow rate.
  3. Maintain the portal vein pressure in the physiological range between 7 - 10 mmHg by adjusting the flow rate.
    NOTE: Nominal flow rate can vary slightly depending on the usage and positioning of tubes.

5. Sample collection

  1. Obtain inlet perfusate samples from the portal vein inflow tube and outlet perfusate samples from the organ chamber in 3h intervals.
  2. Collect samples from all liver lobes for histological analysis at the end of the perfusion period of 12 h.

Access restricted. Please log in or start a trial to view this content.

Results

Establishment of surgical procedure
A total of 17 animals were utilized for this experiment: 14 mice were employed for optimizing the organ procurement process, including cannulation of the portal vein (PV) and bile duct (BD), while 3 mice were used to validate the procedure (Table 1). Histological results (Figure 3) were compared to facilitate the identification of the optimal perfusion condition.

Selection of perfusa...

Access restricted. Please log in or start a trial to view this content.

Discussion

Critical steps in the protocol
The two crucial steps in liver explantation are the cannulation of the portal vein (PV) and the subsequent cannulation of the bile duct (BD). These steps are of paramount importance in ensuring successful organ retrieval and subsequent perfusion or transplantation procedures.

Challenges and solutions
PV cannulation presents three challenges: injury of the vessel wall, displacement of the catheter, and practicability o...

Access restricted. Please log in or start a trial to view this content.

Disclosures

There are no financial conflicts of interest to disclose.

Acknowledgements

Throughout the writing of this paper, I have received a great deal of support and assistance. I would particularly like to acknowledge my teammate XinPei Chen for his wonderful collaboration and patient support during my operation.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.5 ml Micro Tube PPSarstedt72699
1 Fr Rubber CannulaVygonSample Cannula
10 µL Micro SyringeHamilton701N
2 Fr Rubber CannulaVygonSample Cannula
24 G Butterfly CannulaTerumoSR+OF2419
26 G Butterfly CannulaTerumoSR+DU2619WX
30 G Hypodermic NeedleSterican100246
50 ml Syringe PumpBraun110356
6-0 Perma-Hand SeideEthicon639H
Arterial ClipBraunBH014R
Autoclavable Moist ChamberHugo Sachs Elektronik73-4733
Big Cotton Applicator NOBA Verbandmittel Danz GmbH974018
Bubble TrapHugo-Sachs-ElektronikV83163
Buprenovet (0.3 mg / ml)Elanco/
CIDEX OPA solution (2 L)Cilag GmbH20391
Electrosurgical Unit for Monopolar Cutting VIO® 50 CERBE/
Fetal Bovine Serum(500 ml) Sigma-AldrichF7524-500ML
Gas Mixture (95 % oxygen & 5 % carbon dioxide)House Supply/
Heating Circulating BathsHarvard-Apparatus75-0310
Heparin 5000 (I.E. /5 ml)Braun1708.00.00
Hydrocortisone (100 mg / 2 ml)Pfizer15427276
Insulin(100 IE / ml)SigmaI0516-5ML
Iris Scissors Fine Science Instruments15000-03
Isofluran (250 ml)Cp-Pharma1214
Membrane OxygenatorHugo Sachs ElektronikT18728
Microsurgery Microscope LeicaM60
Mouse Retractor Set Carfil Quality180000056
NanoZoomer 2.0 HTHamamatsu/
Non-Woven Sponges Kompressen866110
Penicillin Streptomycin (1 mg / ml) C.C.ProZ-13-M
Perfusion Extension Tube (30 cm)Braun4256000
Peristaltic PumpHarvard-ApparatusP-70
Petri Dishc 100x15 mmVWR®391-0578
Povidon-Jod (Vet-Sep Spray)Livisto799-416
Pressure Transducer SimulatorUTAH Medical Products650-950
Reusable Blood Pressure TransducersAD InstrumentsMLT-0380/D
S & T Vessel Cannulation ForcepsFine Science Instruments00608-11
Small Cotton ApplicatorNOBA Verbandmittel Danz GmbH974116
Straight Forceps 10 cm Fine Science Instruments00632-11
Suture Tying ForcepsFine Science Instruments11063-07
Syringe 50ml Original PerfusorBraun8728810F-06
UT - 03 CannulaUnique Medical, Japan/
Vannas Spring ScissorsFine Science Instruments15018-10
Veterinary Saline (500 ml)WDT18X1807
Water Jacketed Reservoir  2 LHarvard-Apparatus73-3441
William's E Medium (500 ML)Thermofischer ScientificA1217601

References

  1. Kwong, A. J., et al. OPTN/SRTR 2021 Annual data report: liver. American Journal of Transplantation. 23 (2), S178-S263 (2023).
  2. Linares, I., Hamar, M., Selzner, N., Selzner, M. Steatosis in Liver Transplantation: Current Limitations and Future Strategies. Transplantation. 103 (1), 78-90 (2019).
  3. Cheng, N., et al. Pharmacological activating transcription factor 6 activation is beneficial for liver retrieval with ex vivo normothermic mechanical perfusion from cardiac dead donor rats. Frontiers in Surgery. 8, 665260(2021).
  4. Porte, R. J. Improved organ recovery after oxygen deprivation. Nature. 608 (7922), 273-274 (2022).
  5. Goumard, C., et al. Ex-Vivo Pharmacological Defatting of the Liver: A Review. Journal of Clinical Medicine. 10 (6), 1253(2021).
  6. Mao, B., Yuan, W., Wu, F., Yan, Y., Wang, B. Autophagy in hepatic ischemia-reperfusion injury. Cell Death Discovery. 9 (1), 115(2023).
  7. Hale, A. N., Ledbetter, D. J., Gawriluk, T. R., Rucker, E. B. 3rd Autophagy: regulation and role in development. Autophagy. 9 (7), 951-972 (2013).
  8. Tang, B., Bao, N., He, G., Wang, J. Long noncoding RNA HOTAIR regulates autophagy via the miR-20b-5p/ATG7 axis in hepatic ischemia/reperfusion injury. Gene. 686, 56-62 (2019).
  9. Kuma, A., Komatsu, M., Mizushima, N. Autophagy-monitoring and autophagy-deficient mice. Autophagy. 13 (10), 1619-1628 (2017).
  10. van der, V. alk J. Fetal bovine serum-A cell culture dilemma. Science. 375 (6577), 143-144 (2022).
  11. Haque, O., et al. Twenty-four hour ex-vivo normothermic machine perfusion in rat livers. Technology (Singapore World Science). 8 (1-2), 27-36 (2020).
  12. Op den Dries, S., et al. Normothermic machine perfusion reduces bile duct injury and improves biliary epithelial function in rat donor livers. Liver Transplantation. 22 (7), 994-1005 (2016).
  13. Izamis, M. L., et al. Machine perfusion enhances hepatocyte isolation yields from ischemic livers. Cryobiology. 71 (2), 244-255 (2015).
  14. Gassner, J. M. G. V., et al. Improvement of normothermic ex vivo machine perfusion of rat liver grafts by dialysis and kupffer cell inhibition with glycine. Liver Transplantation. 25 (2), 275-287 (2019).
  15. Casado, J., et al. Rat splanchnic net oxygen consumption, energy implications. The Journal of Physiology. 431, 557-569 (1990).
  16. Tolboom, H., et al. A model for normothermic preservation of the rat liver. Tissue Engineering. 13 (8), 2143-2151 (2007).
  17. Yamada, S., et al. Effects of short-term normothermic and subnormothermic perfusion after cold preservation on liver transplantation from donors after cardiac death. Transplantation Proceedings. 52 (6), 1639-1642 (2020).
  18. Behrends, M., et al. Acute hyperglycemia worsens hepatic ischemia/reperfusion injury in rats. Journal of Gastrointestinal Surgery. 14 (3), 528-535 (2010).
  19. Tolboom, H., et al. Sequential cold storage and normothermic perfusion of the ischemic rat liver. Transplant Proceeding. 40 (5), 1306-1309 (2008).
  20. Daemen, M. J., et al. Liver blood flow measurement in the rat. The electromagnetic versus the microsphere and the clearance methods. Journal of Pharmacological Methods. 21 (4), 287-297 (1989).
  21. Koo, A., Liang, I. Y. Microvascular filling pattern in rat liver sinusoids during vagal stimulation. The Journal of physiology. 295, 191-199 (1979).
  22. Beal, E. W., et al. [D-Ala2, D-Leu5] Enkephalin improves liver preservation during normothermic ex vivo perfusion. Journal of Surgical Research. 241, 323-335 (2019).
  23. Birnie, J. H., Grayson, J. Observations on temperature distribution and liver blood flow in the rat. The Journal of Physiology. 116 (2), 189-201 (1952).
  24. Silitonga, M., Silitonga, P. M. Haematological profile of rats (Rattus norvegicus) induced BCG and provided leaf extract of Plectranthus amboinicus Lour Spreng). AIP Conference Proceedings. 1868, 090008090008(2017).
  25. Jacob Filho, W., et al. Reference database of hematological parameters for growing and aging rats. Aging Male. 21 (2), 145-148 (2018).
  26. Tian, X., et al. Heme oxygenase-1-modified bone marrow mesenchymal stem cells combined with normothermic machine perfusion repairs bile duct injury in a rat model of DCD liver transplantation via activation of peribiliary glands through the Wnt pathway. Stem Cells International. 2021, 9935370(2021).
  27. Yang, L., et al. Normothermic machine perfusion combined with bone marrow mesenchymal stem cells improves the oxidative stress response and mitochondrial function in rat donation after circulatory death livers. Stem Cells Development. 29 (13), 835-852 (2020).
  28. Wang, L., He, H. W., Zhou, X., Long, Y. Ursodeoxycholic Acid (UDCA) promotes lactate metabolism in mouse hepatocytes through cholic acid (CA) - farnesoid x receptor (FXR) pathway. Current Molecular Medicine. 20 (8), 661-666 (2020).
  29. Akateh, C., Beal, E. W., Whitson, B. A., Black, S. M. Normothermic ex-vivo liver perfusion and the clinical implications for liver transplantation. Journal of Clinical and Translational Hepatology. 6 (3), 276-282 (2018).
  30. Westerkamp, A. C., et al. Metformin preconditioning improves hepatobiliary function and reduces injury in a rat model of normothermic machine perfusion and orthotopic transplantation. Transplantation. 104 (9), e271-e280 (2020).
  31. Nösser, M., et al. Development of a rat liver machine perfusion system for normothermic and subnormothermic conditions. Tissue Engineering. Part A. 26 (1-2), 57-65 (2020).
  32. Yao, J., et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response. FASEB Journal. 33 (2), 1695-1710 (2019).
  33. Haque, O., et al. The effect of blood cells retained in rat livers during static cold storage on viability outcomes during normothermic machine perfusion. Scientific Reports. 11 (1), 23128(2021).
  34. Gillooly, A. R., Perry, J., Martins, P. N. First report of siRNA uptake (for RNA interference) during ex vivo hypothermic and normothermic liver machine perfusion. Transplantation. 103 (3), e56-e57 (2019).
  35. Beal, E. W., et al. A small animal model of ex vivo normothermic liver perfusion. Journal of visualized experiments. (136), e57541(2018).
  36. Claussen, F., et al. Dual versus single vessel normothermic ex vivo perfusion of rat liver grafts using metamizole for vasodilatation. PLoS One. 15 (7), (2020).
  37. Yang, L., et al. Bone marrow mesenchymal stem cells combine with normothermic machine perfusion to improve rat donor liver quality-the important role of hepatic microcirculation in donation after circulatory death. Cell and Tissue Research. 381 (2), 239-254 (2020).
  38. Wu, L., et al. Bone marrow mesenchymal stem cells modified with heme oxygenase-1 alleviate rejection of donation after circulatory death liver transplantation by inhibiting dendritic cell maturation in rats. International Immunopharmacology. 107, 108643(2022).
  39. Lonati, C., et al. Quantitative Metabolomics of Tissue, Perfusate, and Bile from Rat Livers Subjected to Normothermic Machine Perfusion. Biomedicines. 10 (3), (2022).
  40. Oldani, G., et al. The impact of short-term machine perfusion on the risk of cancer recurrence after rat liver transplantation with donors after circulatory death. PLoS One. 14 (11), e0224890(2019).
  41. Abraham, N., et al. Two compartment evaluation of liver grafts during acellular room temperature machine perfusion (acRTMP) in a rat liver transplant model. Frontiers in Medicine (Lausanne). 9, 804834(2022).
  42. Scheuermann, U., et al. Sirtuin-1 expression and activity is diminished in aged liver grafts. Scientific Reports. 10 (1), 11860(2020).
  43. Scheuermann, U., et al. Damage-associated molecular patterns induce inflammatory injury during machine preservation of the liver: potential targets to enhance a promising technology. Liver Transplantation. 25 (4), 610-626 (2019).
  44. Carnevale, M. E., et al. The novel N, N-bis-2-hydroxyethyl-2-aminoethanesulfonic acid-gluconate-polyethylene glycol-hypothermic machine perfusion solution improves static cold storage and reduces ischemia/reperfusion injury in rat liver transplant. Liver Transplantation. 25 (9), 1375-1386 (2019).
  45. Von,, Horn, C., Zlatev, H., Pletz, J., Lüer, B., Minor, T. Comparison of thermal variations in post-retrieval graft conditioning on rat livers. Artificial Organs. 46 (2), 239-245 (2022).
  46. Tomizawa, M., et al. Oncostatin M in William's E medium is suitable for initiation of hepatocyte differentiation in human induced pluripotent stem cells. Molecular Medicine Reports. 15 (5), 3088-3092 (2017).
  47. Dondossola, D., et al. Human red blood cells as oxygen carriers to improve ex-situ liver perfusion in a rat model. Journal of Clinical medicine. 8 (11), (2019).
  48. Jägers, J., Wrobeln, A., Ferenz, K. B. Perfluorocarbon-based oxygen carriers: from physics to physiology. European Journal of Physiology. 473 (2), 139-150 (2021).
  49. Jia, J., et al. A promising ex vivo liver protection strategy: machine perfusion and repair. Surgery and Nutrition. 8 (2), 142-143 (2019).
  50. Jennings, H., et al. The immunological effect of oxygen carriers on normothermic ex vivo liver perfusion. Frontiers in Immunology. 13, 833243(2022).
  51. Kim, J. S., et al. Carbamazepine suppresses calpain-mediated autophagy impairment after ischemia/reperfusion in mouse livers. Toxicology and Applied Pharmacology. 273 (3), 600-610 (2013).
  52. Imber, C. J., et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation. 73 (5), 701-709 (2002).
  53. Tolboom, H., et al. Recovery of warm ischemic rat liver grafts by normothermic extracorporeal perfusion. Transplantation. 87 (2), 170-177 (2009).
  54. Rigo, F., Navarro-Tableros, V., De Stefano, N., Calleri, N., Romagnoli, A. Ex vivo normothermic hypoxic rat liver perfusion model: an experimental setting for organ recondition and pharmacological intervention. Methods in Molecular Biology. 2269, 139-150 (2021).
  55. van Dyk, J. C., Pieterse, G. M., van Vuren, J. H. Histological changes in the liver of Oreochromis mossambicus (Cichlidae) after exposure to cadmium and zinc. Ecotoxicology and Environmental Safety. 66 (3), 432-440 (2007).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Normothermic Liver PerfusionEx Vivo PerfusionMouse Liver PreservationMachine Perfusion SystemPortal Vein CannulationBile Duct CannulationHeparinized Saline FlushPerfusate AnalysisHematoxylin Eosin StainingMorphological Integrity
Normothermic Ex Vivo Liver Machine Perfusion in Mouse
Contact Us
Recommend to Library

Privacy

Terms of Use

Policies

Copyright © 2026 MyJoVE Corporation. All rights reserved.